Carterra® Inc., formerly Wasatch Microfluidics, was founded in 2004 by Josh Eckman (CEO), Prof. Bruce Gale, Jim Smith and David Chang-Yen, as a spin-out from the University of Utah Department of Mechanical Engineering to develop highly parallel microfluidic devices for drug discovery and life science research applications.

The Carterra team successfully developed and commercialized the patented Continuous Flow Microspotter (CFM) technology, which uses a network of microchannels that uniquely enable flow-based array printing of proteins and antibodies on sensor surfaces. In addition, they coupled the CFM with label-free Surface Plasmon Resonance (SPR) technology to deliver high-resolution data for critical biotherapeutics applications at throughputs 10 – 100 times faster than existing platforms, compressing months of work into days.

Carterra recently raised $10M from Telegraph Hill Partners ( www.thpartners.net ) and launched the fully automated LSA™ Array Surface Plasmon Resonance (Array SPR) instrument, based on the Company’s core CFM technology, SPRi detection and industry leading analytics software.